Charles Scales, MD
MD, Duke University
Dinan MA, Georgieva MV, Li Y, Zhang T, Harrison M, Shenolikar R, et al. Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012. J Geriatr Oncol. 2020 Sep 7;
Boydston K, Terry R, Winship B, Davis L, Yttri S, Carlos E, et al. The Impact of Alternative Alkalinizing Agents on 24-Hour Urine Parameters. In: Urology. 2020. p. 55–9.
Youssef RF, Martin JW, Sakhaee K, Poindexter J, Dianatnejad S, Scales CD, et al. Rising occurrence of hypocitraturia and hyperoxaluria associated with increasing prevalence of stone disease in calcium kidney stone formers. Scand J Urol. 2020 Jul 27;1–5.